Physiolab Technology

Entelos’ PhysioLab technology was adapted from the fields of aerospace engineering, medical decision analysis, and computer science to address problems facing pharmaceutical R&D. The technology has been in development for over 10 years and is protected by multiple patents.

Entelos PhysioLab platforms are developed using a top-down approach that synthesizes quantitative data from thousands of peer-reviewed papers into a single contextual framework, thereby providing a better understanding of human physiology in both health and disease. The models are used to simulat novel therapeutic strategies, new experimental approaches, and clinical trials, all with the aim of predicting downstream human efficacy.

Each PhysioLab system represents dynamic whole-organism physiology, and contains the following features:

  • A comprehensive, graphical disease map showing key pieces of the relevant biology and their linkages to other parts of the model
  • Mathematical equations (systems of differential equations) that quantitatively characterize the dynamic relationships between components over time
  • An extensive reference database of scientific literature including information from public sources and in some cases proprietary data provided by pharmaceutical partners
  • A powerful simulation engine that allows researchers to conduct “what if” experiments to test new intervention strategies in different patient types


For information on Entelos toxicogenomics solutions including DrugMatrix® and ToxFX™, please visit the Iconix website.


Disclaimer (U.S. Visitors)